Cathepsin B

Handbook of Proteolytic Enzymes

Volumn 2, Issue , 2013, Pages 1784-1791

  Mort, John S ^a  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884828155     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382219-2.00406-3     Document Type: Chapter

References (91)

1. Barrett A.J. Introduction to the history and classification of tissue proteinases. Proteinases in Mammalian Cells and Tissues 1977, 1-55. Elsevier/North Holland, Amsterdam. A.J. Barrett (Ed.).
2. Fruton J.S., Irving G.W., Bergmann M. On the proteolytic enzymes of animal tissues. III. The proteolytic enzymes of beef spleen, beef kidney, and swine kidney. Classification of the cathepsins. J. Biol. Chem. 1941, 141:763-774.
3. McDonald J.K., Ellis S. On the substrate specificity of cathepsins B1 and B2 including a new fluorogenic substrate for cathepsin B1. Life Sci. 1976, 1269-1276.
4. Nägler D.K., Ménard R. Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions. FEBS Lett. 1998, 434:135-139.
5. Barrett A.J. Human cathepsin B1. Purification and some properties of the enzyme. Biochem. J. 1973, 131:809-822.
6. Takio K., Towatari T., Katunuma N., Teller D.C., Titani K. Homology of amino acid sequence of rat liver cathepsins B and H with that of papain. Proc. Natl. Acad. Sci. USA 1983, 80:3666-3670.
7. San Segundo B., Chan S.J., Steiner D.F. Identification of cDNA clones encoding a precursor of rat liver cathepsin B. Proc. Natl. Acad. Sci. USA 1985, 82:2320-2324.
8. Aronson N.N., Barrett A.J. The specificity of cathepsin B. Hydrolysis of glucagon at the C- terminus by a peptidyldipeptidase mechanism. Biochem. J. 1978, 171:759-765.
9. 2 specificity for arginine and its role in transition state stabilization. J. Biol. Chem. 1993, 268:235-240.
10. Barrett A.J. A new assay for cathepsin B1 and other thiol proteinases. Anal. Biochem. 1972, 47:280-293.
11. Barrett A.J. An improved color reagent for use in Barrett's assay of cathepsin B. Anal. Biochem. 1976, 76:374-376.
12. Dolbeare F.A., Smith R.E. Flow cytometric measurement of peptidases with use of 5- nitrosalicylaldehyde and 4-methoxy-beta-naphthylamine derivatives. Clin. Chem. 1977, 23:1485-1491.
13. Gráf M., Leemann U., Ruch F., Strauli P. The fluorescence and bright field microscopic demonstration of cathepsin B in human fibroblasts. Histochem. 1979, 64:319-322.
14. Barrett A.J., Kirschke H. Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol. 1981, 80:535-561.
15. Barrett A.J. Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem. J. 1980, 187:909-912.
16. Khouri H.E., Plouffe C., Hasnain S., Hirama T., Storer A.C., Ménard R. A model to explain the pH-dependent specificity of cathepsin B-catalyzed hydrolyses. Biochem. J. 1991, 275:751-757.
17. Mort J.S., Recklies A.D., Poole A.R. Characterization of a thiol proteinase secreted by malignant human breast tumours. Biochim. Biophys. Acta 1980, 614:134-143.
18. Turk B., Dolenc I., Zerovnik E., Turk D., Gubensek F., Turk V. Human cathepsin B is a metastable enzyme stabilized by specific ionic interactions associated with the active site. Biochemistry 1994, 33:14800-14806.
19. 111 in the exopeptidase activity of human cathepsin B. Biochem. J. 2002, 361:613-619.
20. 3 subsite specificity of cathepsin B. J. Biol. Chem. 1995, 270:18036-18043.
21. Shaw E. Cysteinyl proteinases and their selective inactivation. Adv. Enzymol. Relat. Areas Mol. Biol. 1990, 63:271-347.
22. Krantz A. Peptidyl (acyloxy)methanes as quiescent affinity labels for cysteine proteinases. Methods Enzymol. 1994, 244:656-671.
23. Pliura D.H., Bonaventura B.J., Smith R.A., Coles P.J., Krantz A. Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases. Biochem. J. 1992, 288:759-762.
24. Choe Y., Leonetti F., Greenbaum D.C., Lecaille F., Bogyo M., Brömme D., Ellman J.A., Craik C.S. Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J. Biol. Chem. 2006, 281:12824-12832.
25. 1' subsite of cysteine proteases. FEBS Lett. 1993, 328:107-110.
26. 3' variations in extended substrates. Biochem. J. 2000, 347:123-129.
27. Nägler D.K., Tam W., Storer A.C., Krupa J.C., Mort J.S., Ménard R. Interdependency of sequence and positional specificities for cysteine proteases of the papain family. Biochemistry 1999, 38:4868-4874.
28. Recklies A.D., Mort J.S. Characterization of a cysteine proteinase secreted by mouse mammary gland. Cancer Res. 1985, 45:2302-2307.
29. Cygler M., Sivaraman J., Grochulski P., Coulombe R., Storer A.C., Mort J.S. Structure of rat procathepsin B. Model for inhibition of cysteine protease activity by the proregion. Structure 1996, 4:405-416.
30. Turk D., Podobnik M., Kuhelj R., Dolinar M., Turk V. Crystal structures of human procathepsin B at 3.2 and 3.3Å resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide. FEBS Lett. 1996, 384:211-214.
31. Coulombe R., Grochulski P., Sivaraman J., Ménard R., Mort J.S., Cygler M. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 1996, 15:5492-5503.
32. Groves M.R., Taylor A.M.R., Scott M., Cummings N.J., Pickersgill R.W., Jenkins J.A. The prosequence of procaricain forms an α-helical domain that prevents access to the substrate-binding cleft. Structure 1996, 4:1193-1203.
33. Fox T., de Miguel E., Mort J.S., Storer A.C. Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry 1992, 31:12571-12576.
34. Mach L., Mort J.S., Glössl J. Non-covalent complexes between the lysosomal proteinase cathepsin B and its propeptide account for stable, extracellular, high molecular mass forms of the enzyme. J. Biol. Chem. 1994, 269:13036-13040.
35. Poole A.R., Tiltman K.J., Recklies A.D., Stoker T.A.M. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature 1978, 273:545-547.
36. Rowan A.D., Mason P., Mach L., Mort J.S. Rat procathepsin B. Proteolytic processing to the mature form in vitro. J. Biol. Chem. 1992, 267:15993-15999.
37. Mach L., Mort J.S., Glössl J. Maturation of human cathepsin B. Proenzyme activation and proteolytic processing of the precursor to the mature proteinase, in vitro, are primarily unimolecular processes. J. Biol. Chem. 1994, 269:13030-13035.
38. Quraishi O., Storer A.C. Identification of internal autoproteolytic cleavage sites within the prosegments of recombinant procathepsin B and procathepsin S. Contribution of a plausible unimolecular autoproteolytic event for the processing of zymogens belonging to the papain family. J. Biol. Chem. 2001, 276:8118-8124.
39. Pungercar J.R., Caglic D., Sajid M., Dolinar M., Vasiljeva O., Pozgan U., Turk D., Bogyo M., Turk V., Turk B. Autocatalytic processing of procathepsin B is triggered by proenzyme activity. FEBS J. 2009, 276:660-668.
40. Rowan A.D., Feng R., Konishi Y., Mort J.S. Demonstration by electrospray mass spectrometry that the peptidyldipeptidase activity of cathepsin B is capable of rat cathepsin B C-terminal processing. Biochem. J. 1993, 294:923-927.
41. Shirahama-Noda K., Yamamoto A., Sugihara K., Hashimoto N., Asano M., Nishimura M., Hara-Nishimura I. Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice. J. Biol. Chem. 2003, 278:33194-33199.
42. Takayuki T., Schmidt P.G., Tang J. Novel carbohydrate structures of cathepsin B from porcine spleen. J. Biol. Chem. 1984, 259:6059-6062.
43. Takahashi T., Yonezawa S., Dehdarani A.H., Tang J. Comparative studies of two cathepsin B isozymes from porcine spleen. Isolation, polypeptide chain arrangements, and enzyme specificity. J. Biol. Chem. 1986, 261:9368-9374.
44. Hasnain S., Hirama T., Tam A., Mort J.S. Characterization of recombinant rat cathepsin B and non-glycosylated mutants expressed in yeast. New insights into the pH-dependence of cathepsin B catalysed hydrolyses. J. Biol. Chem. 1992, 267:4713-4721.
45. Musil D., Zucic D., Turk D., Engh R.A., Mayr I., Huber R., Popovic T., Turk V., Towatari T., Katunuma N., Bode W. The refined 2.15Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 1991, 10:2321-2330.
46. Illy C., Quraishi O., Wang J., Purisima E., Vernet T., Mort J.S. Role of the occluding loop in cathepsin B activity. J. Biol. Chem. 1997, 272:1197-1202.
47. Renko M., Pozgan U., Majera D., Turk D. Stefin A displaces the occluding loop of cathepsin B only by as much as required to bind to the active site cleft. FEBS J. 2010, 277:4338-4345.
48. Redzynia I., Ljunggren A., Abrahamson M., Mort J.S., Krupa J.C., Jaskolski M., Bujacz G. Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B. J. Biol. Chem. 2008, 283:22815-22825.
49. Starkey P.M., Barrett A.J. Human cathepsin B1. Inhibition by alpha-2-macroglobulin and other serum proteins. Biochem. J. 1973, 131:823-831.
50. Barrett A.J. The cystatins: a new class of peptidase inhibitors. Trends Biochem. Sci. 1987, 12:193-196.
51. Lenarcic B., Ritonja A., Strukelj B., Turk B., Turk V. Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain. J. Biol. Chem. 1997, 272:13899-13903.
52. Stubbs M.T., Laber B., Bode W., Huber R., Jerala R., Lenarcic B., Turk V. The refined 2.4 Å X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: A novel type of proteinase inhibitor interaction. EMBO J. 1990, 9:1939-1947.
53. Pavlova A., Krupa J.C., Mort J.S., Abrahamson M., Björk I. Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration of release of loop anchoring through mutation of His110. FEBS Lett. 2000, 487:156-160.
54. Varughese K.I., Ahmed F.R., Carey P.R., Hasnain S., Huber C.P., Storer A.C. Crystal structure of a papain-E-64 complex. Biochemistry 1989, 28:1330-1332.
55. Yamamoto A., Tomoo K., Hara T., Murata M., Kitamura K., Ishida T. Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex. J. Biochem. (Tokyo) 2000, 127:635-643.
56. Schaschke N., Assfalg-Machleidt I., Machleidt W., Moroder L. Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors. FEBS Lett. 1998, 421:80-82.
57. Buttle D.J., Murata M., Knight C.G., Barrett A.J. CA074 methyl ester: a proinhibitor for intracellular cathepsin B. Arch. Biochem. Biophys. 1992, 299:377-380.
58. Montaser M., Lalmanach G., Mach L. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells. Biol. Chem. 2002, 383:1305-1308.
59. Bogyo M., Verhelst S., Bellingard-Dubouchaud V., Toba S., Greenbaum D. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. Chem. Biol. 2000, 7:27-38.
60. Schaschke N., Assfalg-Machleidt I., Lassleben T., Sommerhoff C.P., Moroder L., Machleidt W. Epoxysuccinyl peptide-derived affinity labels for cathepsin B. FEBS Lett. 2000, 482:91-96.
61. Blum G., von D.G., Merchant M.J., Blau H.M., Bogyo M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat. Chem. Biol. 2007, 3:668-677.
62. Frlan R., Gobec S. Inhibitors of cathepsin B. Curr. Med. Chem. 2006, 13:2309-2327.
63. Rich D.H., Brown M.A., Barrett A.J. Purification of cathepsin B by a new form of affinity chromatography. Biochem. J. 1986, 235:731-734.
64. Sivaraman J., Coulombe R., Magny M.-C., Mason P., Mort J.S., Cygler M. Crystallization of rat procathepsin B. Acta Crystallogr. 1996, D52:874-875.
65. Kuhelj R., Dolinar M., Pungercar J., Turk V. The preparation of catalytically active human cathepsin B from its precursor expressed in Escherichia coli in the form of inclusion bodies. Eur. J. Biochem. 1995, 229:533-539.
66. Ren W.-P., Fridman R., Zabrecky J.R., Morris L.D., Day N.A., Sloane B.F. Expression of functional recombinant human procathepsin B in mammalian cells. Biochem. J. 1996, 319:793-800.
67. Steed P.M., Lasala D., Liebman J., Wigg A., Clark K., Knap A.K. Characterization of recombinant human cathepsin B expressed at high levels in baculovirus. Protein Sci. 1998, 7:2033-2037.
68. Wang X., Chan S.J., Eddy R.L., Byers M.G., Fukushima Y., Henry W.M., Haley L.L., Steiner D.F., Shows T.B. Chromosome assignment of cathepsin B (CTSB) to 8p22 and cathepsin H (CTSH) to 15q24-q25. Cytogenet. Cell Genet. 1987, 46:710-711.
69. Hughes S.J., Glover T.W., Zhu X.X., Kuick R., Thoraval D., Orringer M.B., Beer D.G., Hanash S. A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc. Natl. Acad. Sci. USA 1998, 95:12410-12415.
70. Sitabkhan Y., Frankfater A. Differences in the expression of cathepsin B in B16 melanoma metastatic variants depend on transcription factor Sp1. DNA Cell Biol. 2007, 26:673-682.
71. Szpaderska A.M., Silberman S., Ahmed Y., Frankfater A. Sp1 regulates cathepsin B transcription and invasiveness in murine B16 melanoma cells. Anticancer Res. 2004, 24:3887-3891.
72. Berquin I.M., Sloane B.F. Cathepsin B expression in human tumors. Adv. Exp. Med. Biol. 1996, 389:281-294.
73. Berquin I.M., Cao L., Fong D., Sloane B.F. Identification of two new exons and muliple transcription start points in the 5'-untranslated region of the human cathepsin-B-encoding gene. Gene 1995, 159:143-149.
74. Tam S.W., Cote-Paulino L.R., Peak D.A., Sheahan K., Murnane M.J. Human cathepsin B-encoding cDNAs: sequence variations in the 3'-untranslated region. Gene 1994, 139:171-176.
75. Gong Q., Chan S.J., Bajkowski A.S., Steiner D.F., Frankfater A. Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA. DNA Cell Biol. 1993, 12:299-309.
76. Lemaire R., Flipo R.-M., Migaud H., Fontaine C., Heut G., Dacquembronne E., Lafyatis R. Alternate splicing of the 5' region of cathepsin B pre-messenger RNA in rheumatoid synovial tissue. Arthritis Rheum. 1997, 40:1540-1543.
77. Müntener K., Zwicky R., Csucs G., Rohrer J., Baici A. Exon skipping of cathepsin B: Mitochondrial targeting of a lysosomal peptidase provokes cell death. J. Biol. Chem. 2004, 279:41012-41017.
78. Baici A., Muntener K., Willimann A., Zwicky R. Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death. Biol. Chem. 2006, 387:1017-1021.
79. Mach L., Stüwe K., Hagen A., Ballaun C., Glössl J. Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme. Biochem. J. 1992, 282:577-582.
80. Reddy V.Y., Zhang Q.-Y., Weiss S.J. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 1995, 92:3849-3853.
81. Mai J., Finley R.L., Waisman D.M., Sloane B.F. Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 2000, 275:12806-12812.
82. Mason S.D., Joyce J.A. Proteolytic networks in cancer. Trends Cell Biol. 2011, 21:228-237.
83. Steer M.L. How and where does acute pancreatitis begin?. Arch. Surg. 1992, 127:1350-1353.
84. Burnett D., Abrahamson M., Devalia J.L., Sapsford R.J., Davies R.J., Buttle D.J. Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase. Arch. Biochem. Biophys. 1995, 317:305-310.
85. Baici A., Lang A., Zwicky R., Müntener K. Cathepsin B in osteoarthritis: Uncontrolled proteolysis in the wrong place. Semin. Arthritis Rheum. 2004, 34:24-28.
86. Halangk W., Lerch M.M., Brandt-Nedelev B., Roth W., Ruthenbuerger M., Reinheckel T., Domschke W., Lippert H., Peters C., Deussing J. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Invest. 2000, 106:773-781.
87. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., Kaufmann S.H., Gores G.J. Cathepsin B contributes to TNFα-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 2000, 106:1127-1137.
88. Stoka V., Turk B., Schendel S.L., Kim T.H., Cirman T., Snipas S.J., Ellerby L.M., Bredesen D., Freeze H., Abrahamson M., Brömme D., Krajewski S., Reed J.C., Yin X.M., Turk V., Salvesen G.S. Lysosomal protease pathways to apoptosis: cleavage of bid, not Pro-caspases, is the most likely route. J. Biol. Chem. 2000, 276:3149-3157.
89. Mort J.S., Poole A.R., Decker R.S. The immunofluorescent localization of cathepsins B and D in human fibroblasts. J. Histochem. Cytochem. 1981, 29:649-657.
90. Rowan A.D., Mach L., Mort J.S. Antibodies to rat procathepsin B recognize the active mature enzyme. Biol. Chem. Hoppe-Seyler 1992, 373:427-432.
91. Wardale R.J., Maciewicz R.A., Etherington D.J. Monoclonal antibodies to rabbit liver cathepsin B. Biosci. Rep. 1986, 6:639-646.